Xavier
Carbonell Estrany
Publicaciones en las que colabora con Xavier Carbonell Estrany (3)
2023
-
Prioritising respiratory syncytial virus prevention in low-income and middle-income countries
The Lancet Global Health
2022
2017
-
Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: Update based on the clinical evidence in Spain
BMC Infectious Diseases, Vol. 17, Núm. 1